Key Points
- Director Roy Blunt sold 600 Tenet Healthcare shares at an average price of $262.68, generating $157,608 and reducing his holdings by 11.56% to 4,589 shares.
- Tenet reported strong quarterly results, with earnings of $6.12 per share and revenue of $6.04 billion, exceeding estimates; revenue increased 6.8% year over year. The stock opened at $262.75, near its 52-week high.
- Analysts maintain a “Moderate Buy” consensus, with 17 Buy ratings and three Holds and an average price target of $271.00. Institutional investors own approximately 95.44% of the company.
Tenet Healthcare Corporation (NYSE:THC - Get Free Report) Director Roy Blunt sold 600 shares of the company's stock in a transaction on Wednesday, August 5th. The shares were sold at an average price of $262.68, for a total value of $157,608.00. Following the sale, the director owned 4,589 shares of the company's stock, valued at approximately $1,205,438.52. The trade was a 11.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Tenet Healthcare Stock Up 2.4%
Shares of NYSE THC opened at $262.75 on Friday. The stock has a market capitalization of $21.16 billion, a P/E ratio of 10.13, a PEG ratio of 0.98 and a beta of 1.23. The stock's fifty day moving average is $200.19 and its 200 day moving average is $201.39. Tenet Healthcare Corporation has a 52 week low of $157.58 and a 52 week high of $265.32. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41.
Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business had revenue of $6.04 billion during the quarter, compared to analysts' expectations of $5.43 billion. During the same quarter in the prior year, the business posted $4.02 earnings per share. Tenet Healthcare's revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Sell-side analysts forecast that Tenet Healthcare Corporation will post 21.09 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several research analysts have commented on THC shares. Robert W. Baird boosted their price objective on shares of Tenet Healthcare from $210.00 to $280.00 and gave the company a "neutral" rating in a research report on Tuesday, July 28th. Wells Fargo & Company lifted their price target on Tenet Healthcare from $231.00 to $281.00 and gave the company an "overweight" rating in a research note on Monday. Guggenheim upped their price objective on Tenet Healthcare from $242.00 to $283.00 and gave the stock a "buy" rating in a research report on Tuesday, July 28th. Piper Sandler set a $308.00 price objective on Tenet Healthcare in a research note on Monday, July 27th. Finally, Truist Financial boosted their target price on Tenet Healthcare from $270.00 to $290.00 and gave the stock a "buy" rating in a research note on Tuesday, July 28th. Seventeen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Tenet Healthcare has an average rating of "Moderate Buy" and an average price target of $271.00.
View Our Latest Research Report on Tenet Healthcare
Hedge Funds Weigh In On Tenet Healthcare
Institutional investors and hedge funds have recently bought and sold shares of the company. Triumph Capital Management acquired a new stake in shares of Tenet Healthcare during the third quarter valued at about $25,000. Activest Wealth Management bought a new position in Tenet Healthcare in the 4th quarter valued at approximately $26,000. Elyxium Wealth LLC acquired a new stake in Tenet Healthcare during the 4th quarter worth approximately $29,000. Canada Pension Plan Investment Board bought a new stake in Tenet Healthcare during the 2nd quarter worth approximately $35,000. Finally, Trust Co. of Vermont bought a new position in shares of Tenet Healthcare during the second quarter valued at $37,000. Institutional investors and hedge funds own 95.44% of the company's stock.
About Tenet Healthcare
(
Get Free Report)
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
